CJC-1295
Also known as: CJC-1295 DAC, Drug Affinity Complex-GHRH, Modified GHRH 1-29
Overview
CJC-1295 is a 29-amino acid synthetic analog of growth hormone-releasing hormone (GHRH), structurally based on the first 29 amino acids of native GHRH with four amino acid substitutions to improve stability, plus an attached Drug Affinity Complex (DAC) component. The DAC modification allows covalent binding to serum albumin, dramatically extending the half-life to several days and enabling sustained GH and IGF-1 elevation lasting up to 28 days after a single dose.
Mechanism of Action
CJC-1295 binds to GHRH receptors on pituitary somatotroph cells, activating G-proteins and downstream second messengers (cAMP, IP₃). This triggers protein kinase cascade activation and transcription factor phosphorylation, ultimately driving GH gene transcription and GH secretion. Studies indicate 2-10 fold increases in GH pulse amplitude and 1.5-3 fold increases in IGF-1 levels, with the DAC modification providing sustained albumin-bound reservoir activity.
Potential Benefits
- 2-10 fold increase in growth hormone pulse amplitude
- 1.5-3 fold increase in IGF-1 levels sustained for up to 28 days
- Potential increase in lean muscle mass (~2.77 lbs over 16 weeks in early studies)
- Improved fat metabolism and body composition
- Enhanced recovery and repair processes
- Anti-aging effects via GH/IGF-1 axis optimization
- Prolonged half-life allowing less frequent dosing compared to native GHRH
Dosage Protocols
The following reflects doses used in published research studies. This is not medical advice. Consult a qualified healthcare professional.
| Typical Range | 100-300 mcg/dose, 1-3x/week |
| Beginner | 100 mcg 2x/week |
| Intermediate | 200 mcg 2-3x/week |
| Advanced | 300 mcg 3x/week |
| Cycle Duration | 8-12 weeks |
| Cycle Off | 4-8 weeks |
CJC-1295 with DAC is typically dosed 1-2x/week due to extended half-life. Without DAC (Modified GRF 1-29), dose daily or before sleep. Combine with a GHRP for synergistic GH release (GHRH+GHRP is the gold standard stack).
Use our Reconstitution Calculator to determine exact syringe units for your protocol.
Routes of Administration
Subcutaneous Injection High
Standard route; consistent absorption; inject into abdominal subcutaneous fat
Intramuscular Injection High
Faster peak but similar total exposure; less commonly used for CJC-1295
Read our full Routes of Administration Guide for detailed comparison of all delivery methods.
Stacking Protocols
Popular research stacks involving CJC-1295:
GH Optimization Stack
Maximized GH pulse amplitude with selective, clean release profile
The most popular GHRH+GHRP combination; CJC-1295 provides GH-releasing pulse amplitude while Ipamorelin selectively triggers release without cortisol/prolactin elevation.
Triple GH Stack
Aggressive GH stimulation for advanced users
Adding GHRP-2 further amplifies GH pulse; may increase appetite and slight cortisol elevation. For experienced users only.
Body Recomposition Stack
GH stimulation combined with targeted fat metabolism
AOD-9604 provides direct lipolytic activity while the GHRH/GHRP combination drives anabolic and recovery benefits.
Explore our complete Peptide Stacking Guide for more combinations and safety considerations.
Reconstitution
| Typical Vial Size | 2mg, 5mg |
|---|---|
| BAC Water | 1-2ml per 2mg vial |
| Storage | Refrigerate at 2-8°C after reconstitution |
| Shelf Life | 28 days refrigerated; stable lyophilized for 24+ months at -20°C |
Need exact syringe measurements?
Amino Acid Sequence
Tyr-DAla-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mpa)-NH2 (DAC conjugated)
Side Effects & Safety
- Water retention and bloating
- Increased hunger/appetite stimulation
- Tingling or numbness in extremities
- Potential insulin resistance with long-term use
- Joint pain at high doses
Synergistic Compounds
The following compounds have been studied alongside CJC-1295 for potential complementary or synergistic effects:
Learn More
References & Further Reading
- [object Object]
- [object Object]